The New York Times reported that the Food and Drug Administration (FDA) has issued letters to clinics offering stem cell injections in a clinic setting. The FDA is giving the cited clinics until November 2020 to contact federal regulators. Patients with arthritis pain in knees, shoulders or spines are learning of stem cell injections as potential treatments that “are marketed as having curative or healing properties, but there is no proof that they work or are safe,” according to the article. Full story.